Thesis Abstract

**Abstract
** MicroRNAs (miRNAs) are small non-coding RNAs that play critical roles in the regulation of gene expression and are implicated in various biological processes, including cancer progression. This thesis investigates the role of miRNAs in cancer progression and explores potential therapeutic strategies targeting these molecules. The study aims to provide insights into the mechanisms by which miRNAs contribute to cancer development and progression, as well as to evaluate the therapeutic potential of targeting miRNAs for cancer treatment. The research begins with a comprehensive literature review of the current understanding of miRNAs in cancer, highlighting their involvement in tumor initiation, progression, metastasis, and drug resistance. The review also discusses the challenges and opportunities in targeting miRNAs for cancer therapy, including the development of miRNA-based therapeutics and the potential benefits of combination therapies. The methodology section outlines the experimental approaches used to investigate the role of specific miRNAs in cancer progression, including cell culture studies, animal models, and bioinformatics analyses. The research methodology also includes the identification of potential miRNA targets and the evaluation of their effects on cancer cell behavior and tumor growth. The findings of this study provide new insights into the complex regulatory networks involving miRNAs in cancer progression. The results demonstrate the dysregulation of specific miRNAs in various cancer types and their impact on key signaling pathways involved in tumor growth and metastasis. Moreover, the study identifies potential therapeutic targets for modulating miRNA expression in cancer cells and highlights the importance of personalized medicine approaches in cancer treatment. The discussion section interprets the results in the context of existing literature and discusses the implications of the findings for cancer research and therapy. The discussion also addresses the challenges and future directions in the field of miRNA-based cancer therapy, including the need for further preclinical and clinical studies to validate the efficacy and safety of miRNA-targeted treatments. In conclusion, this thesis provides a comprehensive overview of the role of miRNAs in cancer progression and highlights the potential of targeting miRNAs as a novel therapeutic approach for cancer treatment. The study contributes to the growing body of knowledge on miRNA biology and cancer pathogenesis, offering new opportunities for the development of innovative cancer therapies.

Thesis Overview